Navigation Links
Nanomedical Diagnostics VP Production to Speak at Materials Research Society Spring Meeting
Date:4/11/2017

In the past decade, graphene biosensors have achieved star status in the biomedical field, pushing existing linear detection ranges and sensitivity limits in lab studies. As electronic devices, they are small, easy to operate, and fast, leading biomedical researchers to dream of their use in everything from drug discovery to disease diagnostics to health monitoring. Only one obstacle stood in the way: No one could figure out how to manufacture graphene biosensors at scale…until now. Dr. Mitchell Lerner of Nanomedical Diagnostics will speak at the Materials Research Society (MRS) Spring Meeting in Phoenix, AZ on April 19 to share how the company has broken the mass-manufacturing barrier for graphene biosensors.

“To fabricate graphene biosensors at scale, we had to solve three main problems,” says VP Production Dr. Lerner. “The first is that run-of-the-mill graphene can’t be used for biosensors meant to generate highly-sensitive results. For that kind of exceptional detection, zero-defect graphene is needed, and no one has produced significant volumes of that class of graphene before. The second challenge involves the ability to meld the low-cost world of electronics manufacturing with the groundbreaking material graphene. As an all-electronic product, graphene biosensors theoretically could leverage the high-volume, low-cost fabrication process of computers, but no one knew how. We cracked that with AGILE R100. And the last is rarely discussed. Graphene biosensors will provide current and conductance data, but how is that data translated into results that are relevant for the life science or health application that’s being studied, in a cost-effective, customer-friendly manner? We designed a compact, hand-held reader that connects to the graphene biosensor and outputs automated, real-time analytics pertinent to the customer.”

Nanomedical Diagnostics is a biotech company that is the world’s only provider of graphene biosensor technology, with a mission to transform the healthcare industry with innovative new products that enable cutting-edge life science research, drug discovery applications, and diagnostic and health monitoring platforms. Dr. Lerner, an 11-year veteran of nanomaterials research and production scale up, will be part of the symposium on 2D Materials in the MRS meeting which brings together researchers across disciplines to explore the cutting edge in materials science.

In addition to MRS, Nanomedical Diagnostics will present its graphene biosensor AGILE R100 at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Diego from May 1 through 3.

AGILE R100 is available for commercial sale, for research use only. For more information, visit http://www.nanomedicaldiagnostics.com.

About Nanomedical Diagnostics

Nanomedical Diagnostics (“Nanomed”) is a biotech company based in San Diego, CA. Nanomed has developed a breakthrough electronic assay based on Field Effect Biosensing (FEB) technology that provides real-time, label-free kinetic binding, affinity, and concentration data. Unique graphene biosensors at the heart of the assay deliver highly-sensitive biophysical characterization of small molecules =1 Da in complex media such as DMSO, using unprecedentedly small amounts of sample, making the platform a novel orthogonal option for drug discovery hit validation and lead optimization.

Read the full story at http://www.prweb.com/releases/Nanomedical_Diagnostics/VP_Production_at_MRS/prweb14224831.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Nanomedical Diagnostics Announces Partnership with Rogue Valley Microdevices, Delivering World’s First Successful High-Volume Manufacturing for Graphene Biosensors
2. Nanomedical Diagnostics to Present Field Effect Biosensing for Fragment-Based Drug Discovery at SLAS 2017
3. Nanomedical Diagnostics CEO and CTO to Introduce Electronic Label-Free Assay Based on Field Effect Biosensing Technology at IDTechEx Show
4. Nanomedical Diagnostics launches a new graphene biosensor with unprecedented functionality for small molecule and protein analysis
5. Nanomedical Diagnostics Announces Scientific Advisory Board of Top Scientists and Medical Researchers
6. EU Adopts New Diagnostics and Medical Device Regulations, USDM Life Sciences Helps Organizations Comply
7. Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards
8. Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs
9. Global Licensing Partnering Report: Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016 - Research and Markets
10. SQI Diagnostics Reports First Quarter 2017 Results
11. Paradigm Diagnostics Announces $7M Series B Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage ... its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats ... sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the ...
(Date:10/11/2017)... ... 11, 2017 , ... Personal eye wash is a basic first aid supply for any work ... which eye do you rinse first if a dangerous substance enters both eyes? It’s one ... with its unique dual eye piece. , “Whether its dirt and debris, or an ...
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
Breaking Biology Technology:
(Date:8/15/2017)... Aug. 15 2017   ivWatch LLC , a medical device ... therapy, today announced receipt of its ISO 13485 Certification, the global ... International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection of ... "This is an important milestone ...
(Date:6/23/2017)... N.Y. , June 23, 2017  IBM (NYSE: ... dairy research, today announced a new collaboration using next-generation ... chances that the global milk supply is impacted by ... Cornell University has become the newest academic institution to ... a food safety initiative that includes IBM Research, Mars, ...
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
Breaking Biology News(10 mins):